Sickle cell and autoimmune disease: a double whammy

Autor: Arne M. de Kreuk

Publikováno v: Haematologica, Vol 999, Iss 1 (2024)

Not available.

Externí odkaz: https://doaj.org/article/7b08fb24e2144e90acfe957d75abdb3b

199. Short versus Extended Antibiotic Treatment with a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients with Fever of Unknown Origin: A Randomized Multicenter Noninferiority Trial

Autor: Sonja Zweegman, Jeroen Janssen, Juleon Coenen, Paula F. Ypma, Wies Vasmel, Birgit I. Lissenberg-Witte, Michiel A. van Agtmael, Andries E. Budding, Nick A. de Jonge, Jonne J. Sikkens, Arne M. De Kreuk, Aart Beeker, Alexandra H E Herbers, Mark H.H. Kramer

Publikováno v: Open Forum Infectious Diseases

Background In hematology patients with high risk neutropenia due to intensive chemotherapy the optimal antibiotic treatment duration for fever of unknown origin (FUO) is unknown. Early antibiotic discontinuation has been advocated to reduce unnecessa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f36443f3cb363c33b46c7528218df55
https://doi.org/10.1093/ofid/ofaa439.509

F-18-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma

Autor: Josien C. Regelink, Josée M. Zijlstra, Paul Lips, Nikie J. Hoetjes, Pieter Sonneveld, Nathalie Bravenboer, M. van Duin, R. Milek, A. M. de Kreuk, Marielle J. Wondergem, Sonja Zweegman, Pieter G. Raijmakers

Publikováno v: Regelink, J C, Raijmakers, P G, Bravenboer, N, Milek, R, Hoetjes, N J, de Kreuk, A M, van Duin, M, Wondergem, M J, Lips, P, Sonneveld, P, Zijlstra, J M & Zweegman, S 2016, ' F-18-fluoride-PET for dynamic in vivo monitoring of bone formation in multiple myeloma ', EJNMMI Research, vol. 6, 46 . https://doi.org/10.1186/s13550-016-0197-4
EJNMMI Research, 6. Springer-Verlag
EJNMMI Research, 6:46. Springer Berlin
EJNMMI Research

Background Bone disease in multiple myeloma is characterized by reduced bone formation. The gold standard of bone formation is the mineral apposition rate (MAR), an invasive technique reflecting bone formation at a single site. We compared 18F-fluori

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bfed342554ec48300aa8077c22596a6
https://pure.eur.nl/en/publications/a0e13481-7fcf-4069-947d-6e859b8aa02b

Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days

Autor: A. R. Jonkhoff, J. W. Van Oostveen, Adri Zevenbergen, Gerrit Jan Schuurhuis, Peter C. Huijgens, Gert J. Ossenkoppele, A. M. De Kreuk, E. C. M. Hendriks, Angelika M. Dräger

Publikováno v: Bone Marrow Transplantation. 28:145-155

Autologous stem cell transplantation using unprocessed, G-CSF-mobilized whole blood (WB) is a simple, cost-reducing procedure and supports high-dose chemotherapy regimens not exceeding 72 h. Thereafter, clonogenic capacity rapidly decreases if routin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf40e647a5d5c58f19c650439144020
https://doi.org/10.1038/sj.bmt.1703127

Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases

Autor: M. de Haas, L. Porcelijn, Elly Huiskes, A. M. De Kreuk, R Maatman

Publikováno v: Vox sanguinis, 95(4), 324-330. Wiley-Blackwell

Background Acquired Glanzmann's thrombasthenia (GT) is an uncommon bleeding disorder caused by glycoprotein (GP) IIb/IIIa-specific autoantibodies. Covering of the fibrinogen binding site of GPIIb/IIIa results in a moderate-to-severe bleeding tendency

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d718f58cfd2c930559a9b783cc612c
https://pubmed.ncbi.nlm.nih.gov/19138263